Table 1 Trial characteristics for 28 505 subjects.
| Trial | No. | Inclusion criteria | Age, mean (years) | Women (%) | DM (%) | Prior MI (%) | Double blind | Intention to treat | Mean F/U Years (% complete) | |
|---|---|---|---|---|---|---|---|---|---|---|
| A to Z,10 2004 | 4 497 | Recent ACS | 61 | 24 | 24 | 17 | Y | Y | 2.0 (97.0) | |
| PROVE‐IT TIMI 22,11 2004 | 4 162 | Recent ACS | 58 | 22 | 18 | 18 | Y | Y | 2.0 (99.8) | |
| IDEAL,12 2005 | 8 888 | Stable CHD with prior MI | 62 | 19 | 12 | 100 | N | Y | 4.8 (99.8) | |
| TNT,13 2005 | 10 001 | Stable CHD with objective evidence | 61 | 19 | 15 | 58 | Y | Y | 4.9 (99.2) | |
| VASCULAR BASIS,14 2005 | 300 | Stable CHD with inducible ischaemia | 64 | 14 | 16 | 39 | Y | N | 1.0 (84.7) | |
| REVERSAL,15 2004 | 657 | Stable CHD with 20–50% stenosis | 56 | 28 | 19 | NA | Y | N | 1.5 (76.9) |
ACS, acute coronary syndrome; CHD, coronary heart disease; DM, diabetes mellitus; MI, myocardial infarction; F/U, follow‐up; Y, yes; N, no.